QRG Capital Management’s CareDx CDNA Stock Holding History

QRG Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-21,801	Closed	-$426K	–	1059
2025 Q2	$426K	Buy	+21,801	New	+$387K	﹤0.01%	860

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

QRG Capital Management's CDNA Position: Q3 2025 in Review

QRG Capital Management sold out of CareDx (CDNA) in Q3 2025, closing a stake of 21,801 shares — an estimated $426K sold.

QRG Capital Management first reported a position in CDNA in Q2 2025 and held it in 1 quarter. The position peaked at $426K in Q2 2025. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

QRG Capital Management reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
QRG Capital Management sold 21,801 CareDx shares in Q3 2025, an estimated $426K.
QRG Capital Management first reported a position in CareDx in Q2 2025 and held it in 1 quarter.
QRG Capital Management's CareDx position peaked at $426K in Q2 2025.
187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on QRG Capital Management's 13F filing for Q3 2025, filed 28 Oct 2025.